Chin Surgery — Cost, Top Hospitals & Success Rates | MyMedicPlus

Chin surgery encompasses a range of surgical procedures directed at altering the size, shape, symmetry, and projection of the chin (mentum) to achieve facial harmony. It is performed by plastic surgeons and oral and maxillofacial surgeons and spans augmentation, reduction, and complex three-dimensional repositioning. The chin forms the lower anchor of the face and its proportions directly influence perceptions of the nose, neck, and overall facial character.

The broad category of chin surgery includes: chin augmentation using silicone or porous polyethylene implants; osseous genioplasty (sliding genioplasty) in which the chin bone is osteotomised and repositioned; and chin reduction, which removes bone or soft tissue to reduce an excessively prominent chin (macrogenia). In cases where chin abnormalities are part of a wider jaw relationship problem — malocclusion, skeletal class II or III — chin surgery may be performed as a component of comprehensive orthognathic surgery.

Patients are evaluated with standardised facial photographs, dental occlusion assessment, and where applicable, cone beam CT scanning or cephalometric X-rays to precisely quantify the chin's position relative to the rest of the facial skeleton and dentition. Treatment planning is now frequently performed using digital surgical simulation software that models the expected outcome of different surgical approaches. The final surgical decision balances aesthetic goals, skeletal anatomy, dental relationships, and the patient's tolerance for surgical complexity and recovery duration.

Microgenia (small chin) and retrogenia (posteriorly positioned chin) are the most common reasons patients seek chin surgery, creating a facial profile with a recessed lower face, apparent nasal prominence, and a poor cervicomental angle. These conditions occur as isolated anomalies or as part of Class II skeletal malocclusion (retrognathic mandible). Macrogenia (excessively large chin) causes the opposite imbalance, where the chin dominates the lower face, appearing heavy or masculine in a female patient, or disproportionately large in a male.

Chin asymmetries — either horizontal (lateral deviation) or vertical (excess or deficiency of chin height) — are also correctable with osseous genioplasty, which offers precision in multiple planes unavailable with implant augmentation alone. Post-traumatic deformities following mandibular fractures, congenital anomalies such as hemifacial microsomia, and residual deformities after tumour resection or radiation are reconstructive indications for chin surgery. Gender affirmation surgery includes both chin augmentation (masculinisation) and chin reduction with recontouring (feminisation).

Ideal candidates for chin surgery are skeletally mature adults (typically 18 years or older, as the mandible continues developing into the mid-teens) with a specific chin anomaly that creates functional or significant aesthetic impairment and who have realistic outcome expectations. Patients with chin hypoplasia as an isolated finding are well-suited for implant augmentation, while those with complex three-dimensional deformities, previous implant failure, or concurrent malocclusion are better served by osseous genioplasty. Preoperative dental occlusion must be assessed to determine whether orthognathic surgery is required concurrently.

Contraindications include active perioral infections, significant dental caries or periodontal disease that would increase intraoral infection risk, severe bleeding diatheses, uncontrolled systemic conditions (uncontrolled diabetes, active autoimmune disease), or body dysmorphic disorder. Patients with unrealistic expectations — requesting extreme changes in chin size or shape beyond what anatomy will accommodate — require psychological screening before surgery. Smokers are strongly advised to cease for a minimum of 4–6 weeks pre- and post-operatively due to the detrimental effects of nicotine on wound healing and bone healing after osteotomy.

Alloplastic chin augmentation with silicone implants remains the most commonly performed technique for microgenia and mild retrogenia. Extended anatomical implants that augment the lateral body of the mandible as well as the central chin point are used when a broader improvement in jawline definition is desired. Implants are placed via a submental or intraoral approach in a subperiosteal pocket, with or without screw fixation.

Osseous genioplasty (sliding genioplasty) offers unparalleled versatility: the chin bone can be advanced, set back, moved inferiorly to increase chin height, superiorly to reduce height, or moved laterally to correct asymmetry, and combinations of these movements are simultaneously achievable. The technique uses a horizontal osteotomy below the mental foramina and rigid titanium plate fixation. Chin reduction surgery removes bony prominence by burring or osteotomy of the anterior symphysis under direct vision. For gender feminisation, both bone reduction and soft tissue debulking contribute to the final appearance. Vertical reduction genioplasty reduces excess vertical chin height, which is commonly associated with a long lower face.

Individualised treatment planning is essential to achieve optimal outcomes. Factors including patient age, overall health status, concurrent medications, and personal goals all influence the selection and sequencing of treatment approaches. A specialist consultation — with review of relevant investigations and prior treatment history — is the appropriate first step before any therapeutic intervention is initiated. Patients are encouraged to seek a second opinion for complex or elective procedures to ensure they understand all available options and their respective risks, benefits, and costs.

Chin surgery reliably and permanently alters the chin's position and size in ways not achievable non-surgically. Patient satisfaction across all chin surgery techniques exceeds 85% in systematic reviews, with the highest satisfaction in patients who undergo comprehensive preoperative planning with digital simulation. The improvement in facial profile — particularly the chin-nose-neck triangle — is among the most transformative of all facial surgeries relative to the modest scale of intervention.

Osseous genioplasty in particular offers permanent, predictable results with no risk of implant-related complications such as infection, malposition, or bone resorption over time. Recovery is rapid relative to more complex jaw surgeries (such as bimaxillary osteotomy), with most patients achieving near-normal oral function within 2–4 weeks and bony healing complete by 8–12 weeks. When combined with other facial procedures such as rhinoplasty or face lifting, chin surgery contributes significantly to the overall aesthetic transformation.

For implant-based chin augmentation, risks include infection (1–2%), implant malposition requiring revision, long-term bone resorption beneath the implant, and mental nerve neuropraxia causing temporary lip and chin numbness. Permanent mental nerve damage causing persistent numbness occurs in less than 1% of cases in experienced hands. Extrusion of the implant through intraoral incisions is a rare but serious complication.

For osseous genioplasty, the primary additional risk is damage to the mental nerves during osteotomy, which can cause prolonged numbness lasting 6–12 months before full recovery in most cases. Malunion or non-union of the osteotomy site occurs rarely (less than 1%) and may require hardware revision. Plate infection or hardware failure requiring removal affects fewer than 2% of cases. Swelling after osseous genioplasty is more substantial and longer-lasting than after implant surgery, and patients should be counselled to expect oedema for 4–8 weeks. Relapse of bone position can occur if the osteotomy is not adequately stabilised.

After chin implant surgery, recovery involves 1–2 weeks of moderate swelling with a soft diet and chin bandage support for the first 5 days. Return to normal activities occurs within 2–3 weeks and contact sports after 6 weeks. For osseous genioplasty, swelling is more pronounced, persisting for 4–8 weeks. A liquid or soft diet is maintained for 2–4 weeks and vigorous chewing avoided until bony healing is confirmed radiographically at 6–8 weeks.

All chin surgery patients are reviewed at 1 week for wound inspection, 4 weeks for swelling assessment, and 3 months for final photographic outcomes documentation. Radiographic follow-up (panoramic X-ray or CBCT) is standard after osseous genioplasty to confirm osseous union and plate position. Patients should contact the surgical team immediately if they develop expanding swelling, purulent discharge, fever, or sudden asymmetry, which may signal haematoma, infection, or implant displacement.

In the United States, chin augmentation surgery costs USD 3,000–7,000 and osseous genioplasty USD 5,000–12,000, including surgeon fees, anaesthesia, and facility charges. In the UK private sector, costs range from GBP 2,500–6,000. These figures do not include preoperative consultation, imaging, or post-operative revision if required.

Medical tourism for chin surgery delivers savings of 50–75%. In Thailand (Bangkok), renowned for facial cosmetic surgery, costs are USD 1,500–3,500; in South Korea (Seoul) USD 2,000–5,000; in India (Mumbai, Delhi) USD 700–2,500; in Turkey (Istanbul) USD 1,200–3,000. Patients should select board-certified plastic or maxillofacial surgeons at hospitals with JCI accreditation or equivalent national certification, review surgical portfolios and patient outcomes, and plan for at least 1–2 weeks post-operative recovery time before travelling home.

Patients are encouraged to obtain itemised quotes from multiple providers and clarify what is included in the quoted price — surgeon fees, anaesthesiologist fees, facility/hospital charges, pre-operative tests, and follow-up appointments. Cost transparency and written cost estimates before committing to treatment are important consumer protections in private healthcare settings.

Non-surgical chin augmentation with hyaluronic acid or calcium hydroxylapatite dermal fillers provides temporary chin projection for 12–18 months without surgery or significant downtime, and is useful for previewing the aesthetic result before committing to surgery. Costs are USD 500–1,500 per treatment but ongoing maintenance injections are required.

For patients with chin deformity as part of a broader dental or skeletal malocclusion, orthognathic surgery addressing the full jaw relationship may be preferable to isolated chin surgery. Orthodontic treatment improves dental alignment but cannot address skeletal chin deficiency. For patients with mild chin retrusion wishing to avoid surgery entirely, careful rhinoplasty or non-surgical nose reshaping can sometimes create the impression of improved chin-nose proportions without directly altering the chin.